J. Miguel Oliveira

J. Miguel Oliveira BSc, PhD, FBSE (Portuguese, M, 48 years old) is a Principal Investigator with Habilitation at the 3B’s Research Group, member of the PT Government Associate Laboratory ICVS/3B’s (https://3bs.uminho.pt/people/94) and Institute 3Bs (I3Bs), University of Minho (Portugal). He is the Vice President of I3Bs, President Elect of the Scientific Council of I3Bs. Currently, he is a Lecturer in Doctoral Program in Tissue Engineering, Regenerative Medicine and Stem Cells (TERM&SC) at UMinho, PT (since Dec. 2013). Over the years, he has focused his work on the field of biomaterials for tissue engineering, nanomedicine, stem cells, and cell/drug delivery. He also set up a new research line within the ICVS/3B’s on 3D in vitro models for cancer research. In addition, he was member of the National Ethics Committee for Clinical Trials from Serviço Nacional de Saúde (SNS, PT) (Jan. 2021- Aug. 2024). As a result of his proficiency, he has published so far more than 500 scientific contributions in scientific journals with the referee. He has been awarded several prizes including the prestigious “Investigador FCT 2012 and Investigador FCT 2015” attributed by FCT (Portugal), and Jean Leray Award 2015 from European Society for Biomaterials for Young Scientists for Outstanding Contributions within the field of Biomaterials. In Nov. 2023, Dr. Oliveira has been appointed Fellow Biomaterials Science and Engineering (FBSE) for the excellent professional standing and high achievements in the field of biomaterials science and engineering. He is very active on the elaboration and scientific coordination of several PT and international funded projects. He is the coordinator of the project EngVIPO – Engineering Vascularized Implants for Personalised Osteochondral Tissue Regeneration: From medical imaging to pre-clinical validation (https://engvipo.i3bs.eu/) funded from the European Union’s Horizon Europe (HORIZON-MSCA-2023-SE-01-01) under the Grant Agreement Number 101183041. He is the Editor-in-chief of the In vitro Models Journal (Springer, first IF of 2.4 in 2024). He is one of the Editors of the Book Series on Biomaterials, Bioengineering and Sustainability (Springer Nature).